IP Library Granted Patent US 9,096,768
Granted Patent B2
US 9,096,768 · App. 13/968,014 · Granted Aug 4, 2015

Curable phase change ink compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,096,768
App. No.
13/968,014
Granted
Aug 4, 2015
Kind
B2
Abstract

A phase change ink composition is provided comprising a UV-curable component, a crystalline component, and an amorphous component, wherein the addition of a UV-curable component imparts improved robustness over the ink that contains only crystalline and amorphous materials.

Claims (22)

1. A phase change ink composition comprising:

a UV-curable component,

a mono-amide crystalline component having an aromatic ring, wherein the aromatic ring is selected from the group consisting of a benzene group and a naphthalene group; and

an amorphous component.

2. The composition of claim 1 , wherein the crystalline and amorphous components are blended in a weight ratio of from about 60:40 to about 95:5, respectively.

3. The composition of claim 1 , wherein the UV curable component and the crystalline component are blended in a weight ratio of from about 40:60 to about 5:95.

4. The composition of claim 1 , wherein the amorphous component has a viscosity of from about 1 to about 100 cps at a temperature of about 140° C.

5. The composition of claim 1 , wherein the amorphous component has a Tg value of from about 10 to about 50° C.

6. The composition of claim 1 , wherein the UV curable component is (2-hydroxyl ethyl) isocyanurate triacrylate.

7. A phase change ink composition comprising:

a UV-curable component;

a crystalline component,

an amorphous component selected from the group consisting of a polycyclic mono-amide and a polycyclic diamide.

8. The composition of claim 7 , wherein the crystalline and amorphous components are blended in a weight ratio of from about 60:40 to about 95:5, respectively.

9. The composition of claim 7 , wherein the UV curable component and the crystalline component are blended in a weight ratio of from about 40:60 to about 5:95.

10. The composition of claim 7 , wherein the crystalline component exhibits crystallization (Tcrys) and melting (Tmelt) peaks according to differential scanning calorimetry and the difference between the peaks (Tmelt−Tcrys) is less than 55° C.

11. The composition of claim 7 , wherein the UV curable component is (2-hydroxyl ethyl) isocyanurate triacrylate.

12. A phase change ink composition comprising:

a UV-curable component;

a crystalline component that is N-phenylethylbenzamide;

an amorphous component that is 4-tert-butyl cyclohexyl, cyclohexyl tartrate.

13. The composition of claim 12 , wherein the crystalline component and amorphous component are blended in a weight ratio of from about 60:40 and 95:5 respectively.

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2025
From: XEROX CORPORATION
To: GENESEE VALLEY INNOVATIONS, LLC
Reel/Frame 073842/0479 →
SECOND LIEN NOTES PATENT SECURITY AGREEMENT Recorded Jul 2, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 071785/0550 →
FIRST LIEN NOTES PATENT SECURITY AGREEMENT Recorded Apr 11, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 070824/0001 →
SECURITY INTEREST Recorded Feb 13, 2024
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066741/0001 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT RF 064760/0389 Recorded Feb 13, 2024
From: CITIBANK, N.A., AS COLLATERAL AGENT
To: XEROX CORPORATION
Reel/Frame 068261/0001 →
SECURITY INTEREST Recorded Nov 20, 2023
From: XEROX CORPORATION
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065628/0019 →
SECURITY INTEREST Recorded Jun 22, 2023
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 064760/0389 →
RELEASE OF SECURITY INTEREST IN PATENTS AT R/F 062740/0214 Recorded May 18, 2023
From: CITIBANK, N.A., AS AGENT
To: XEROX CORPORATION
Reel/Frame 063694/0122 →
SECURITY INTEREST Recorded Nov 10, 2022
From: XEROX CORPORATION
To: CITIBANK, N.A., AS AGENT
Reel/Frame 062740/0214 →